Skip to main content

Telo Genomics Corp(TELO-X)
TSX Venture

Today's Change
Delayed Last Update

Telo Genomics Corp

2255 York Avenue
Suite 203
Vancouver BC V6K 1C5 CAN
P: 604-999-3693
https://www.telodx.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.

    Key Executives

    NameTitle
    Sabine MaiCEO/Director/Founder
    Christopher RossCFO

    More from The Globe

    UBS Group’s U.S. turnaround hobbled by heavy wealth management losses, analysts and sources say
    A logo of Swiss bank UBS on a building at the Paradeplatz in Zurich, Switzerland, March 19, 2026. REUTERS/Denis Balibouse
    Insider Report: Chair sells $5-million from this stock yielding 5.8% that’s doubled in under a year
    The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022. THE CANADIAN PRESS/Nathan Denette
    Canaccord reworks U.S. leadership in wake of regulatory settlement
    The logo for Canaccord Genuity is shown in Toronto on Wednesday, March 8, 2023. THE CANADIAN PRESS/Staff
    Bullish on FirstEnergy Corp.
    Monica Rizk
    The most oversold and overbought stocks on the TSX
    The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
    Monday’s analyst upgrades and downgrades
    A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson
    opinion
    Why are Canadian bank valuations so low?
    Tom Bradley
    number cruncher
    Eleven U.S. semiconductor stocks showing strength
    For Number Cruncher column in Globe Investor/ROB only.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.